These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6380285

  • 1. Multicenter clinical trial of cefoperazone sodium in the United States.
    Cohen MS, Washton HE, Barranco SF.
    Am J Med; 1984 Jul 31; 77(1B):35-41. PubMed ID: 6380285
    [Abstract] [Full Text] [Related]

  • 2. [Multicenter study of cefoperazone in Austria].
    Forenbacher HH.
    Wien Med Wochenschr; 1985 Mar 15; 135(5):123-6. PubMed ID: 3993050
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerability of cefoperazone in patients with nosocomial infections].
    Albano O, Palasciano G, Morelli N, Monno D, Velardi A, Tardi S, Malvestiti FM.
    Clin Ter; 1988 Jul 31; 126(2):97-100. PubMed ID: 2974382
    [No Abstract] [Full Text] [Related]

  • 4. Multicenter clinical trials of cefoperazone in Japan.
    Saito A, Ueda Y.
    Clin Ther; 1984 Jul 31; 7(1):49-59. PubMed ID: 6394129
    [Abstract] [Full Text] [Related]

  • 5. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X, Jian L, Xia X, Jia B, Huang W, Li C, Wang C, Zhou L, Sun X, Tang X, Huang Y, Zhu Y, Zhang W.
    Ann Clin Microbiol Antimicrob; 2013 Dec 09; 12():38. PubMed ID: 24321187
    [Abstract] [Full Text] [Related]

  • 6. Asian multicenter trial of cefoperazone in respiratory tract infection.
    Matsumoto K, Chung HY, Hsieh WC.
    Clin Ther; 1984 Dec 09; 6(6):824-38. PubMed ID: 6391668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Worldwide clinical experience with cefoperazone.
    Gerber AU, Craig WA.
    Drugs; 1981 Dec 09; 22 Suppl 1():108-18. PubMed ID: 6456884
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ciprofloxacin: an update on clinical experience.
    Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R.
    Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT, Lu Y, Hou J, Chen YF, Miao JZ, Jia YX, Hou J, Zhang XZ, Chen DK, Hu WZ, Li LJ, Liu DM, Wang Z, Wu J, Gu JM, Wang HL, Zhang YL, Sun L.
    Clin Infect Dis; 1997 Mar 27; 24(3):498-505. PubMed ID: 9114206
    [Abstract] [Full Text] [Related]

  • 14. Cefoperazone sodium in the treatment of serious bacterial infections in 2,100 adults and children: multicentered trials in Europe, Latin America, and Australasia.
    Gordon AJ, Phyfferoen M.
    Rev Infect Dis; 1983 Mar 27; 5 Suppl 1():S188-99. PubMed ID: 6221390
    [Abstract] [Full Text] [Related]

  • 15. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
    Winston DJ, Ho WG, Bruckner DA, Gale RP, Champlin RE.
    Am J Med; 1988 Jul 25; 85(1A):21-30. PubMed ID: 3041815
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Yoshida M, Ichikawa Y, Kido M, Ninomiya K, Kitahara Y, Hara N, Tsurutani H.
    Jpn J Antibiot; 1990 Feb 25; 43(2):239-56. PubMed ID: 2194054
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.